Wellgistics Health, Inc. (WGRX) Form 8-K — Jun 12, 2026
Wellgistics Health (WGRX) received a Nasdaq extension to avoid delisting due to negative stockholders' equity of $12.4 million, which violates the $2.5 million minimum requirement. The company has until October 12, 2026, to demonstrate compliance, primarily through a proposed merger with DataVault AI and acquisition of Tollo Health, which it claims will result in $40 million in equity and $4 billion in assets. Separately, the company resolved a second compliance issue regarding its stock price. Nasdaq confirmed that WGRX regained compliance with the $1.00 minimum bid price requirement as of June 8, 2026, closing that matter.
Key figures
- Minimum Bid Price
- 1
- Minimum Stockholders Equity
- 2500000
- Estimated Combined Asset Value
- 4000000000
- Estimated Post Transaction Equity
- 40000000
- Compliance Deadline
- 2026-10-12
- Bid Price Compliance Period End
- 2026-06-08
Price after filing
Close on the filing date to close N calendar days later (from $3.72). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.